tiprankstipranks
Trending News
More News >
China Pharma Holdings (CPHI)
:CPHI
US Market
Advertisement

China Pharma Holdings (CPHI) Price & Analysis

Compare
275 Followers

CPHI Stock Chart & Stats

$1.55
-$0.04(-14.93%)
At close: 4:00 PM EST
$1.55
-$0.04(-14.93%)

China Pharma Holdings News

CPHI FAQ

What was China Pharma Holdings’s price range in the past 12 months?
China Pharma Holdings lowest stock price was $1.19 and its highest was $3.36 in the past 12 months.
    What is China Pharma Holdings’s market cap?
    China Pharma Holdings’s market cap is $5.07M.
      When is China Pharma Holdings’s upcoming earnings report date?
      China Pharma Holdings’s upcoming earnings report date is May 15, 2025 which is 177 days ago.
        How were China Pharma Holdings’s earnings last quarter?
        Currently, no data Available
        Is China Pharma Holdings overvalued?
        According to Wall Street analysts China Pharma Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does China Pharma Holdings pay dividends?
          China Pharma Holdings does not currently pay dividends.
          What is China Pharma Holdings’s EPS estimate?
          China Pharma Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does China Pharma Holdings have?
          China Pharma Holdings has 3,262,002 shares outstanding.
            What happened to China Pharma Holdings’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of China Pharma Holdings?
            Currently, no hedge funds are holding shares in CPHI

            Company Description

            China Pharma Holdings

            China Pharma Holdings, Inc. (CPHI) is a pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products, particularly focusing on prescription drugs, over-the-counter medications, and health supplements. The company operates primarily in the Chinese market but also aims to expand its presence internationally. CPHI specializes in various therapeutic areas, including cardiovascular diseases, infectious diseases, and gastrointestinal disorders, leveraging its proprietary technologies to enhance drug formulations and delivery systems.
            Similar Stocks
            Company
            Price & Change
            Follow
            Sonoma Pharmaceuticals
            Evoke Pharma
            Shineco
            Sunshine Biopharma
            Universe Pharmaceuticals
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis